Abstracts Archive - Page 1024 of 2425 - ACR Meeting Abstracts

Abstract Number: 289 • 2018 ACR/ARHP Annual Meeting
Adherence of Etanercept in Iraqi Patients with Rheumatoid Arthritis: One- and Five-Year Data from a Local Registry
Nizar Abdulateef Al Ani¹, Faiq Isho Gorial¹, Eman Khedir², Ahmed Hussein², Yasser El Dershaby³ and Ali AlJabban⁴, ¹Baghdad Teaching Hospital, College of Medicine, Baghdad University, Baghdad, Iraq, ²Baghdad Teaching Hospital, Rheumatology Department, Baghdad University, Baghdad, Iraq, ³Pfizer, Dubai, United Arab Emirates, ⁴Pfizer, Baghdad, Iraq
Background/Purpose: Real-world data on adherence to TNFα inhibitors in patients with RA are missing from many regions, including the Middle East. This study evaluated the…
Abstract Number: 290 • 2018 ACR/ARHP Annual Meeting
Emergency Department (ED) Utilization Among SLE Patients and Controls in the Population-Based Michigan Lupus Epidemiology & Surveillance (MILES) Cohort
Jiha Lee¹, Amrita Padda², Wendy Marder¹, Siobán Harlow³, Afton L. Hassett⁴, Suzanna Zick⁵, Charles G. Helmick⁶, Kamil E. Barbour⁶, Caroline Gordon⁷, Deeba Minhas¹, W. Joseph McCune¹ and Emily C. Somers⁸, ¹Rheumatology, University of Michigan, Ann Arbor, MI, ²University of Michigan, Ann Arbor, MI, ³Epidemiology Department- School of Public Health, Obstetrics and Gynecology- Medical School, University of Michigan, Ann Arbor, MI, ⁴Anesthesiology, University of Michigan, Ann Arbor, MI, ⁵Department of Family Medicine, University of Michigan, Ann Arbor, MI, ⁶Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ⁷Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ⁸Internal Medicine-Rheumatology, University of Michigan, Ann Arbor, MI
Background/Purpose: SLE patients frequent the emergency department (ED) irrespective of their access to care, which raises concerns regarding the quality of care in the…
Abstract Number: 291 • 2018 ACR/ARHP Annual Meeting
Factors Associated with High-Dose Corticosteroid Use in SLE Patients Post Initiation of SLE Therapy
Krista Schroeder¹, Steve Gelwicks¹, Jim Paik² and Robert W. Hoffman¹, ¹Eli Lilly and Company, Indianapolis, IN, ²HEOR, Eli Lilly and Company, Indianapolis, IN
Background/Purpose: Systemic lupus erythematosus (SLE) therapies include non-steroidal anti-inflammatory drugs, antimalarials, systemic immunosuppressants, and biologics with corticosteroids as necessary. The majority of these current therapies…
Abstract Number: 292 • 2018 ACR/ARHP Annual Meeting
Derivation of a National Rheumatoid Arthritis Cohort in the Veterans Health Administration and Validation with the Veterans Affairs Rheumatoid Arthritis Registry
Bryant R. England¹, Punyasha Roul², Brian Sauer³, Shaobo Pei⁴, Grant W. Cannon⁵, Joshua Baker⁶ and Ted R. Mikuls⁷, ¹Rheumatology, VA Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, ²University of Nebraska Medical Center, Omaha, NE, ³Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ⁴University of Utah, Salt Lake City, UT, ⁵Division of Rheumatology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ⁶Philadelphia VA Medical Center and University of Pennsylvania, Philadelphia, PA, ⁷VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE
Background/Purpose: The Veterans Health Administration health system represents the largest integrated healthcare system in the U.S. and maintains robust administrative and clinical data that can…
Abstract Number: 293 • 2018 ACR/ARHP Annual Meeting
Temporal Trends and Factors Associated with Bisphosphonate Drug Holidays
Jeffrey R. Curtis¹, Rui Chen¹, Tarun Arora¹, Shanette Daigle¹, Robert Matthews¹, Huifeng Yun¹, Nicole Wright², Ayesha Jaleel³, Elizabeth Delzell⁴ and Kenneth Saag⁵, ¹University of Alabama at Birmingham, Birmingham, AL, ²Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ³University of Alabama at Birmingham, Birmngham, AL, ⁴Retired - University of Alabama at Birmingham, Birmingham, AL, ⁵UAB, Birmingham, AL
Background/Purpose: Safety concerns related to osteoporosis (OP) medication use and temporary or permanent cessation of bisphosphonate therapy (e.g. ‘drug holidays’) have generated appreciable attention in…
Abstract Number: 294 • 2018 ACR/ARHP Annual Meeting
Physical Therapists’ Ability to Recognize Inflammatory Arthritis Cases and Awareness of Importance for Their Prompt Referral to Rheumatology
Debbie Ehrmann Feldman¹, Tatiana Orozco², Jonathan El-Khoury¹, Maude Laliberté¹, Sasha Bernatsky³, Kadija Perreault⁴, François Desmeules², Roland Grad⁵, Michel Zummer⁶, Denis Pelletier⁷, Jean Légaré⁸ and Linda Woodhouse⁹, ¹Université de Montréal, Montréal, QC, Canada, ²Université de Montréal, Montreal, QC, Canada, ³Divisions of Rheumatology and Clinical Epidemiology, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ⁴Université Laval, Québec, QC, Canada, ⁵McGill University, Montreal, QC, Canada, ⁶Rheumatology, Ch Maisonneuve-Rosemont, Montreal, QC, Canada, ⁷OPPQ, Montreal, QC, Canada, ⁸CAPA, Quebec, QC, Canada, ⁹University of Alberta, Edmonton, AB, Canada
Background/Purpose: Early referral to rheumatology of persons with suspected inflammatory rheumatic disease is associated with better outcomes. Persons with undiagnosed rheumatic disease may directly consult…
Abstract Number: 295 • 2018 ACR/ARHP Annual Meeting
Implementing a Staff Tobacco Cessation Protocol Increases Quit Line Referrals in a Community Rheumatology Practice
Ann M. Chodara¹, Edmond Ramly^2,3, Douglas White⁴, Heather Johnson⁵, Andrea Gilmore-Bykovskyi⁶ and Christie M. Bartels⁷, ¹Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ²Industrial and Systems Engineering, University of Wisconsin College of Engineering, Madison, WI, ³Department of Family Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁴Gundersen Lutheran - Onalaska Clinic, Onalaska, WI, ⁵Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁶University of Wisconsin School of Nursing, Madison, WI, ⁷Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: Smoking remains the leading preventable cause of US mortality and predicts higher incidence, greater severity, and reduced treatment response in many rheumatologic conditions. Despite…
Abstract Number: 296 • 2018 ACR/ARHP Annual Meeting
Does Care By a Multidisciplinary Team Improve Outcomes in Rheumatoid Arthritis? a Randomized Controlled Study
Manjari Lahiri^1,2, Peter P.M. Cheung^1,2, Preeti Dhanasekaran², Su Ren Wong³, Ai Yap³, Daphne Tan³, Amelia Santosa^1,2 and Phillip HC Phan², ¹Division of Rheumatology, University Medicine Cluster, National University Hospital, Singapore, Singapore, Singapore, ²Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, ³Department of Rehabilitation, National University Hospital, Singapore, Singapore, Singapore
Background/Purpose: Quality standards recommend an annual review by a multidisciplinary team (MDT) for all patients with rheumatoid arthritis (RA); however, this is based on expert…
Abstract Number: 297 • 2018 ACR/ARHP Annual Meeting
Hospitalization Rates Among Patients with Polymyalgia Rheumatica: A Population-Based Study from 1995-2017
Shafay Raheel¹, Cynthia S. Crowson², Sara J. Achenbach² and Eric L. Matteson³, ¹St. Joseph's Hospital, Chicago, IL, ²Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: The study purpose was to determine whether patients with polymyalgia rheumatica (PMR) are at greater risk for all-cause hospitalizations compared to the general population.Methods:…
Abstract Number: 298 • 2018 ACR/ARHP Annual Meeting
Factors Affecting Inpatient Mortality in Hospitalizations for Sepsis with Underlying Systemic Lupus Erythematosus: Data from the National Inpatient Sample 2010-2014
Karan Chugh¹, Karan Jatwani², Jasleen Kaur³ and Shraddha Jatwani⁴, ¹Division of Pulmonary, Critical Care & Sleep, Wayne State University/Detroit Medical Center, Detroit, MI, ²Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital, New York, NY, ³Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, ⁴Department of Internal Medicine, Division of Rheumatology, Henry Ford Allegiance Health, Jackson, MI
Background/Purpose: Infections are associated with significant morbidity and mortality in systemic lupus erythematosus (SLE). Clinical outcomes of SLE patients hospitalized is variable due to variable…
Abstract Number: 299 • 2018 ACR/ARHP Annual Meeting
A Comparison of Persistent Versus Limited Frequent Emergency Department (ED) Utilization Among Systemic Lupus Erythematosus (SLE) Patients
Judith Lin¹, Jiha Lee², Lisa Gale Suter³ and Liana Fraenkel⁴, ¹Rheumatology, Yale Univeristy School of Medicine, New Haven, CT, ²Rheumatology, University of Michigan School of Medicine, Ann Arbor, MI, ³Rheumatology, Rheumatology, Yale University School of Medicine, New Haven, CT, New Haven, CT, ⁴Yale University School of Medicine, New Haven, CT
Background/Purpose: Patients with SLE often require additional medical management outside of the outpatient setting from ED visits to hospital admissions. Previous studies in the general…
Abstract Number: 300 • 2018 ACR/ARHP Annual Meeting
Built-in-Electronic-Medical-Record Disease Activity Calculators and Treat-to-Target in Rheumatoid Arthritis
Arundathi Jayatilleke¹ and Scott Pompa², ¹Department of Rheumatology, Drexel Rheumatology, Philadelphia, PA, ²Rheumatology, Drexel Rheumatology, Philadelphia, PA
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory arthritis that, if undertreated, can lead to cumulative damage and disability. The goal of treatment is to…
Abstract Number: 301 • 2018 ACR/ARHP Annual Meeting
Rheumatology Clinic Staff Needs for Partnering to Improve Blood Pressure and Tobacco Risk Management
Michelle Tong¹, Laura Block², Andrea Gilmore-Bykovskyi², Edmond Ramly³ and Christie M. Bartels⁴, ¹Biomedical Engineering, University of Wisconsin - Madison, Madison, WI, ²University of Wisconsin School of Nursing, Madison, WI, ³Department of Family Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁴Rheumatology/Medicine, University of Wisconsin - Madison, Madison, WI
Background/Purpose: Patients with rheumatologic conditions are at a higher risk of cardiovascular disease (CVD) than peers. High blood pressure (BP) and tobacco use exacerbate CVD…
Abstract Number: 302 • 2018 ACR/ARHP Annual Meeting
Validity and Responsiveness of Inflammation and Joint Damage Scores Based on the Omeract Rheumatoid Arthritis MRI Scoring System
Ulf Sundin¹, Mikkel Østergaard², Daniel Glinatsi³, Anna-Birgitte Aga⁴, Kim Hørslev-Petersen⁵, Merete Lund Hetland⁶, Peter Junker⁷, Bo Jannik Ejbjerg⁸, Paul Bird⁹, Philip G. Conaghan¹⁰, Siri Lillegraven⁴ and Espen A. Haavardsholm⁴, ¹*Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup Copenhagen Center for Arthritis Research, Copenhagen, Denmark, ³Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark, ⁴Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁵King Christian 10th Hospital for Rheumatic Diseases, University of Southern Denmark, Institute of Regional Health Research, Graasten, Denmark, ⁶Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, The DANBIO Registry, Glostrup, Denmark, ⁷Odense University Hospital, Odense, Denmark, ⁸Department of Rheumatology, Zealand University Hospital, Køge, Denmark, ⁹Medicine, University of New South Wales, Sydney, NSW, Australia, ¹⁰University of Leeds, Leeds, United Kingdom
Background/Purpose: The RAMRIS scoring system is used to quantify synovitis, tenosynovitis, bone marrow edema (BME), bone erosions and joint space narrowing (JSN) on MRI examinations…
Abstract Number: 303 • 2018 ACR/ARHP Annual Meeting
The Value of the Simplified Ramris-5 in Early RA Patients Under Methotrexate Therapy Using High Field MRI
Philipp Sewerin¹, Miriam Frenken², Daniel Benjamin Abrar², Christine Goertz³, Christoph Schleich⁴, Matthias Schneider⁵ and Benedikt Ostendorf¹, ¹Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Düsseldorf, Germany, ²Department for diagnostic and interventional Radiology, Heinrich-Heine-Universitiy, Duesseldorf, Germany, ³Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine-Universitiy, Duesseldorf, Germany, ⁴Department for diagnostic and interventional Radiology, Heinrich-Heine University, Duesseldorf, Germany, ⁵Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Duesseldorf, Germany
Background/Purpose: The aim of the study was to evaluate a simplified version of the Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) to five joints of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].